BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Srivastava SP, Goodwin JE. Cancer Biology and Prevention in Diabetes. Cells 2020;9:E1380. [PMID: 32498358 DOI: 10.3390/cells9061380] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Santolla MF, Talia M, Cirillo F, Scordamaglia D, De Rosis S, Spinelli A, Miglietta AM, Nardo B, Filippelli G, De Francesco EM, Belfiore A, Lappano R, Maggiolini M. The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells. Cells 2022;11:2402. [DOI: 10.3390/cells11152402] [Reference Citation Analysis]
2 Di Fusco SA, Cianfrocca C, Bisceglia I, Spinelli A, Alonzo A, Mocini E, Gulizia MM, Gabrielli D, Oliva F, Imperoli G, Colivicchi F. Potential pathophysiologic mechanisms underlying the inherent risk of cancer in patients with atherosclerotic cardiovascular disease. Int J Cardiol 2022:S0167-5273(22)00947-0. [PMID: 35724799 DOI: 10.1016/j.ijcard.2022.06.048] [Reference Citation Analysis]
3 Liu XY. The High Prevalence of Short-Term Elevation of Tumor Markers Due to Hyperglycemia in Diabetic Patients. Diabetes Metab Syndr Obes 2022;15:1113-22. [PMID: 35431565 DOI: 10.2147/DMSO.S350599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Benbrook DM, Hocker JRS, Moxley KM, Hanas JS. Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases. Int J Mol Sci 2022;23:3277. [PMID: 35328698 DOI: 10.3390/ijms23063277] [Reference Citation Analysis]
5 Stancic A, Saksida T, Markelic M, Vucetic M, Grigorov I, Martinovic V, Gajic D, Ivanovic A, Velickovic K, Savic N, Otasevic V, Srivastava S. Ferroptosis as a Novel Determinant of β-Cell Death in Diabetic Conditions. Oxidative Medicine and Cellular Longevity 2022;2022:1-19. [DOI: 10.1155/2022/3873420] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Liu X, Zheng K, Ji W, Zhang W, Li Y, Liu M, Cui J, Li W. Effects of Diabetes on Inflammatory Status and Prognosis in Cancer Patients. Front Nutr 2022;9:792577. [DOI: 10.3389/fnut.2022.792577] [Reference Citation Analysis]
7 Ding J, Li X, Ge J, Gong Y, Zhou Y, Xiao J, Yang Q, Chen J, Mao M. Survival Risk Analysis of Small Cell Lung Cancer Patients with Pre-Existing Type 2 Diabetes Mellitus: A Single-Center Retrospective Cohort Study. CMAR 2022;Volume 14:1313-22. [DOI: 10.2147/cmar.s340334] [Reference Citation Analysis]
8 Tseng C. Pioglitazone and Risk of Chronic Obstructive Pulmonary Disease in Patients with Type 2 Diabetes Mellitus: A Retrospective Cohort Study. COPD 2022;Volume 17:285-95. [DOI: 10.2147/copd.s345796] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Benedetti R, Benincasa G, Glass K, Chianese U, Vietri MT, Congi R, Altucci L, Napoli C. Effects of novel SGLT2 inhibitors on cancer incidence in hyperglycemic patients: a meta-analysis of randomized clinical trials. Pharmacol Res 2021;175:106039. [PMID: 34929299 DOI: 10.1016/j.phrs.2021.106039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
10 Olatunde A, Nigam M, Singh RK, Panwar AS, Lasisi A, Alhumaydhi FA, Jyoti Kumar V, Mishra AP, Sharifi-Rad J. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs. Cancer Cell Int 2021;21:499. [PMID: 34535145 DOI: 10.1186/s12935-021-02202-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
11 Leng W, Jiang J, Chen B, Wu Q. Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]. Diabetes Metab Syndr Obes 2021;14:3947-8. [PMID: 34526792 DOI: 10.2147/DMSO.S336807] [Reference Citation Analysis]
12 Frantsiyants EM, Surikova EI, Kaplieva IV, Bandovkina VA, Neskubina IV, Sheiko EA, Morozova MI, Kotieva IM. [Diabetes mellitus and cancer: a system of insulin-like growth factors]. Probl Endokrinol (Mosk) 2021;67:34-42. [PMID: 34766488 DOI: 10.14341/probl12741] [Reference Citation Analysis]
13 Leng W, Jiang J, Chen B, Wu Q. Metformin and Malignant Tumors: Not Over the Hill. Diabetes Metab Syndr Obes 2021;14:3673-89. [PMID: 34429626 DOI: 10.2147/DMSO.S326378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
14 Srivastava SP, Srivastava R, Chand S, Goodwin JE. Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease. Pharmaceuticals (Basel) 2021;14:751. [PMID: 34451848 DOI: 10.3390/ph14080751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Talib WH, Mahmod AI, Abuarab SF, Hasen E, Munaim AA, Haif SK, Ayyash AM, Khater S, Al-Yasari IH, Kury LTA. Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products. Molecules 2021;26:2179. [PMID: 33920079 DOI: 10.3390/molecules26082179] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
16 Dąbrowski M. Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors. Int J Mol Sci 2021;22:1680. [PMID: 33562380 DOI: 10.3390/ijms22041680] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Srivastava SP, Kanasaki K, Goodwin JE. Loss of Mitochondrial Control Impacts Renal Health. Front Pharmacol 2020;11:543973. [PMID: 33362536 DOI: 10.3389/fphar.2020.543973] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
18 Zhou J, Zhu J, Yu SJ, Ma HL, Chen J, Ding XF, Chen G, Liang Y, Zhang Q. Sodium-glucose co-transporter-2 (SGLT-2) inhibition reduces glucose uptake to induce breast cancer cell growth arrest through AMPK/mTOR pathway. Biomed Pharmacother 2020;132:110821. [PMID: 33068934 DOI: 10.1016/j.biopha.2020.110821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]